Welcome to our dedicated page for AUNA S.A. SEC filings (Ticker: AUNA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Auna S.A. (NYSE: AUNA) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer. Auna files an annual report on Form 20-F and furnishes current information on Form 6-K, which together document its activities as a Latin American healthcare platform operating in Mexico, Peru, and Colombia. These filings include press releases on financial results, financing transactions, and operational milestones, as well as management’s discussion and analysis of financial condition and results of operations for specified periods.
Recent Form 6-K submissions reference quarterly financial results, including unaudited condensed consolidated interim financial statements, and discuss performance across Auna’s healthcare facilities and health plan portfolio. Other 6-K filings relate to proposed and completed offerings of senior secured notes, a significant debt refinancing, and cash tender offers and consent solicitations for outstanding notes. Through these documents, readers can follow how Auna describes its leverage ratios, debt maturity profile, and capital structure objectives.
Auna’s filings also incorporate disclosures on strategic initiatives. Examples include the expansion of its OncoMexico network through partnerships with medical institutions, a public–private partnership with EsSalud in Peru for the Torre Trecca outpatient treatment center, and a Memorandum of Understanding with Sojitz Corporation of America to explore healthcare opportunities in Latin America. These items appear in press releases that are furnished to the SEC as exhibits to Form 6-K reports.
On Stock Titan, users can review Auna’s 20-F and 6-K filings as they become available from EDGAR and use AI-powered summaries to interpret key points. This includes simplified explanations of annual and interim financial reporting, context around debt and note offerings, and highlights from operational and strategic disclosures, all based on the information Auna provides in its official filings.
Auna S.A. (AUNA) filed a 6-K/A updating H1 activity. For the six months ended June 30, 2025, the Group incurred factoring costs of S/ 10,419 thousand (S/ 10,174 thousand in H1 2024). The update clarifies certain working capital measures exclude taxes and prepayments, and that outstanding claims reserves reflect third‑party obligations within the insurance program.
Auna invested in growth and facility upgrades. During the six months ended June 30, 2025, the Group acquired assets with a cost of S/ 30,098 thousand (S/ 23,857 thousand in H1 2024). Additions to constructions in progress totaled S/ 10,744 thousand (S/ 11,908 thousand in H1 2024), tied to real estate projects expanding Clínica Delgado, Clínica Miraflores and Clínica Vallesur in Peru, with remodeling at clinics in Barranquilla, Montería and Medellín, and projects at hospitals in Mexico.
Auna S.A. filed a Form 6-K noting it has commenced a cash tender offer and consent solicitation for any and all of its outstanding 10.000% Senior Secured Notes due 2029, as disclosed in an attached press release.
The press release is listed as Exhibit 99.1 and is dated October 20, 2025. The filing provides notice of the action; specific financial terms, amounts, and timelines are contained in the referenced press release.
Bank of Nova Scotia filed an amended Schedule 13G reporting ownership of 1,140,197 shares of AUNA S.A. common stock, representing